Sumitomo Mitsui Trust Group Inc. decreased its holdings in shares of Solventum Co. (NYSE:SOLV - Free Report) by 14.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 320,275 shares of the company's stock after selling 52,014 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.19% of Solventum worth $21,157,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the business. Modus Advisors LLC purchased a new stake in shares of Solventum in the fourth quarter valued at about $25,000. Copeland Capital Management LLC purchased a new stake in shares of Solventum in the third quarter valued at about $26,000. Crews Bank & Trust purchased a new stake in shares of Solventum in the fourth quarter valued at about $32,000. True Wealth Design LLC raised its holdings in shares of Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company's stock valued at $33,000 after purchasing an additional 471 shares during the last quarter. Finally, Prospera Private Wealth LLC purchased a new stake in shares of Solventum in the third quarter valued at about $35,000.
Wall Street Analyst Weigh In
SOLV has been the subject of a number of research analyst reports. Mizuho initiated coverage on shares of Solventum in a report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 price objective for the company. Piper Sandler raised their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a "neutral" rating in a report on Friday, November 8th. Finally, Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, Solventum currently has a consensus rating of "Hold" and a consensus target price of $68.29.
Get Our Latest Analysis on SOLV
Solventum Stock Performance
Shares of SOLV stock traded down $0.28 during trading hours on Friday, hitting $74.04. 1,081,408 shares of the company's stock were exchanged, compared to its average volume of 875,989. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $96.05. The business's 50 day simple moving average is $70.75 and its 200-day simple moving average is $68.58. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.
About Solventum
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Articles
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
